Skip to main content
. 2014 Oct 9;4:55. doi: 10.1186/s13550-014-0055-1

Table 1.

Patient characteristics

n Mean Range
Patients (n) 50
Age (years) 67 41 to 77
PSA (ng/ml) 37 2.7 to 168
Gleason score 8 6 to 10
Estimated risk of locoregional lymph node metastases (%)a 32 3.3 to 80.3

aAccording to the Cagiannos pre-treatment nomogram, where age, pre-treatment PSA, clinical tumour stage, primary and secondary Gleason grade, and the number of positive and negative biopsy cores influence the estimated risk.